An engaging mix of author interviews and expert commentary on the latest articles from Clinical Gastroenterology and Hepatology, hosted by the AGA journals' online editor, John F. Kuemmerle, MD, AGAF.
Withdrawal of Immunomodulators After Co-treatment Does Not Reduce Trough Level of Infliximab in Crohn's Disease Patients
14:19A study in the March 2015 issue of CGH finds that withdrawal of immunomodulators after at least 6 months of co-treatment with infliximab does not reduce the trough levels of infliximab in patients with Crohn's disease.
Development of Fecal Microbiota Transplantation
17:36An article in the February issue of CGH looks at solutions to issues concerning fecal microbiota transplantation, and challenges involving this increasingly common procedure that still remain. Dr. Kuemmerle speaks with author Dr. Alexander Khoruts.
Gastrointestinal Bleeding After Implantation of Ventricular Assist Devices
14:36An article in the January issue of CGH investigated the incidence, etiology, and outcome of GI bleeding in patients with ventricular assist devices. Dr. Kuemmerle speaks to co-author Dr. John Vargo of the Cleveland Clinic.
Mesalamine Dosage and Fecal Calprotectin in Patients With Quiescent Ulcerative Colitis
15:20A study in the November issue of CGH investigated whether increasing doses of mesalamine reduces concentrations of fecal calprotectin in patients with quiescent ulcerative colitis. Dr. Kuemmerle speaks to author Dr. James D. Lewis.
How Gastroenterologists Can Demonstrate Value
19:24An AGA Board Strategic Update article in the October issue of CGH discusses recent changes to how a gastroenterologist demonstrates value in the era of the Affordable Care Act. Dr. Kuemmerle speaks to Dr. Lawrence Kosinski.
Restarting Infliximab in IBD Patients with Prior Loss of Response
17:32An article and accompanying editorial in the September issue of CGH discuss reinitiating infliximab therapy for inflammatory bowel disease patients after a period of discontinuation. Dr. Kuemmerle speaks w/ editorial co-author Dr. Maria T. Abreu.
Evolution of Hepatitis C Virus Treatment
16:36An editorial in the August issue of CGH discusses changing treatment methods for Hepatitis C Virus infection over the last several years. Dr. Kuemmerle speaks to first author Dr. Fasiha Kanwal of Baylor College of Medicine.
Management of Dyslipidemia as a Cardiovascular Risk Factor in NAFLD Patients
11:03An article in the July issue of CGH looks at management of dyslipidemia as a cardiovascular risk factor in patients with nonalcoholic fatty liver disease (NAFLD). Dr. Kuemmerle speaks to Dr. Kathleen Corey
PPIs and NSAID–Related Lower Gastrointestinal Adverse Events
13:44A commentary in the June issue of CGH looks at the effect of proton pump inhibitors (PPIs) and nonsteroidal anti-inflammatory drugs (NSAIDs) on the lower gastrointestinal tract. Dr. Kuemmerle speaks to author Dr. Francis KL Chan.
History, Genetics, and Strategies for Cancer Prevention in Lynch Syndrome
17:34A review article in the May issue of CGH looks at the major advances in risk assessment, molecular genetics, DNA mutational analyses, and cancer prevention and management of Lynch syndrome over the last 100 years; with guest Dr. Fay Kastrinos